Vontobel Holding Ltd. Neurocrine Biosciences Inc Transaction History

Vontobel Holding Ltd.

$29.2 Billion
Q3 2024

A detailed history of Vontobel Holding Ltd. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Vontobel Holding Ltd. holds 14,590 shares of NBIX stock, worth $1.83 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

14,590

Previous 12,951 12.66%

Holding current value

$1.83 Million

Previous $1.78 Million 5.78%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$114.58 - $153.15 $187,796 - $251,012	1,639 Added 12.66%	14,590 $1.68 Million
Q2 2024 Aug 13, 2024	BUY	$130.86 - $143.19 $628,258 - $687,455	4,801 Added 58.91%	12,951 $1.78 Million
Q1 2024 May 10, 2024	BUY	$130.4 - $143.74 $76,414 - $84,231	586 Added 7.75%	8,150 $1.12 Million
Q4 2023 Jun 03, 2024	SELL	$106.07 - $132.76 $251,279 - $314,508	-2,369 Reduced 28.01%	6,089 $802,000
Q4 2023 Jan 29, 2024	SELL	$106.07 - $132.76 $277,585 - $347,432	-2,617 Reduced 25.7%	7,564 $996,000
Q3 2023 Jun 03, 2024	SELL	$94.02 - $117.1 $117,525 - $146,375	-1,250 Reduced 12.88%	8,458 $951,000
Q3 2023 Oct 10, 2023	SELL	$94.02 - $117.1 $117,525 - $146,375	-1,250 Reduced 10.94%	10,181 $1.15 Million
Q2 2023 Jun 03, 2024	SELL	$89.53 - $104.87 $53,270 - $62,397	-595 Reduced 5.78%	9,708 $915,000
Q2 2023 Jul 24, 2023	SELL	$89.53 - $104.87 $53,270 - $62,397	-595 Reduced 4.95%	11,431 $1.08 Million
Q1 2023 Jun 03, 2024	BUY	$94.11 - $123.02 $202,618 - $264,862	2,153 Added 26.42%	10,303 $1.04 Million
Q1 2023 Apr 12, 2023	BUY	$94.11 - $123.02 $828,638 - $1.08 Million	8,805 Added 273.36%	12,026 $1.22 Million
Q4 2022 Feb 14, 2023	SELL	$106.72 - $127.06 $282,167 - $335,946	-2,644 Reduced 45.08%	3,221 $384,000
Q3 2022 Nov 04, 2022	BUY	$92.03 - $107.81 $88,256 - $103,389	959 Added 19.55%	5,865 $603,000
Q2 2022 Jul 27, 2022	SELL	$75.79 - $100.07 $2.67 Million - $3.52 Million	-35,189 Reduced 87.76%	4,906 $482,000
Q1 2022 May 13, 2022	BUY	$72.45 - $94.81 $1.32 Million - $1.73 Million	18,222 Added 83.31%	40,095 $3.71 Million
Q4 2021 Feb 14, 2022	BUY	$79.65 - $106.22 $309,838 - $413,195	3,890 Added 21.63%	21,873 $1.85 Million
Q3 2021 Oct 29, 2021	SELL	$86.18 - $99.03 $119,445 - $137,255	-1,386 Reduced 7.16%	17,983 $1.72 Million
Q2 2021 Aug 06, 2021	BUY	$89.43 - $102.27 $301,736 - $345,058	3,374 Added 21.09%	19,369 $1.88 Million
Q1 2021 May 11, 2021	SELL	$87.57 - $119.4 $250,275 - $341,245	-2,858 Reduced 15.16%	15,995 $1.56 Million
Q4 2020 Feb 12, 2021	BUY	$86.91 - $108.33 $1.64 Million - $2.04 Million	18,853 New	18,853 $2.22 Million

Others Institutions Holding NBIX

# of Institutions

625

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.

Account

Vontobel Holding Ltd. Neurocrine Biosciences Inc Transaction History